Ashwagandha: What the Evidence Actually Supports, and the Safety Talk You Need to Have.

The article · 8 min read

How we sourced this. Every claim below is tied to a named study: a meta-analysis, a randomised trial, or the live trial registry, and linked. We graded the evidence too: where it’s moderate, we say so; where it’s early or thin, we say that; and where there’s a real safety signal, we flag it plainly. On a supplement with documented liver-injury reports, a citation you can’t stand behind is worse than none at all, so the safety section was checked against every cited source. Last updated 27 October 2026.

The adaptogen your clients keep bringing up

Ashwagandha went from Ayurvedic obscurity to the best-selling adaptogen on the shelf, and now it’s in your gym’s group chat. Does it actually lower stress? Will it help me sleep? Does it boost testosterone? Is it safe to just take every day?

So we did the boring, valuable thing: pulled the meta-analyses and the strongest randomised trials, graded them, and checked the trial registry for what’s still unsettled. Here’s what the evidence actually supports, and, unlike creatine, this is one where the honest answer includes a real safety conversation. Written so you can use it with a client today.

One framing up front: ashwagandha is genuinely interesting for stress and sleep, meaningfully oversold for muscle, and the one popular supplement where “it’s natural, so it’s safe” is the sentence that gets a client into trouble. Your value as a coach is holding all three of those at once.

What it actually does: stress and anxiety

This is the strongest part of the story. A 2024 systematic review and meta-analysis of nine randomised controlled trials (558 adults) found ashwagandha lowered scores on the Perceived Stress Scale by a mean of 4.72 points and cut Hamilton Anxiety scores versus placebo.¹ A separate 2026 meta-analysis of ten trials reached the same direction and graded the certainty as low-to-moderate: real effects, but with a lot of variation between studies.²

The mechanism people point to is the stress-hormone axis, and the hormone data backs it up: a 2026 meta-analysis of 23 trials found cortisol dropped substantially with supplementation (SMD −1.18), a strong biological signal, though results varied a lot between trials.⁸ Dose matters less than you’d think, a 2024 dose-ranging trial found a measurable stress reduction from as little as 125 mg/day, in a dose-dependent pattern.³

Evidence grade: moderate. Multiple meta-analyses agree on direction; heterogeneity between trials and short durations keep it from “strong.”

Sleep: a small, real effect

If a client’s problem is winding down at night, this is a fair thing to try. A 2021 meta-analysis of five RCTs (400 adults) found a small but statistically real improvement in overall sleep (SMD −0.59), with the effect clearly larger at doses of 600 mg/day or more, durations of 8 weeks or more, and in people actually diagnosed with insomnia.⁴ A well-cited 2020 trial found the biggest gains in sleep-onset latency and efficiency in the insomnia group specifically.⁵

Translation for the gym floor: it’s not a sedative and it won’t knock anyone out. It’s a modest nudge that shows up over weeks, mostly in stressed or poor-sleeping clients, which, to be fair, is a lot of them.

Evidence grade: moderate, and stronger in insomnia than in already-good sleepers.

Strength and body composition: real, but don’t oversell it

Here’s where the marketing runs ahead of the science. The headline RCT, from 2015, had young men new to lifting take 600 mg/day for eight weeks alongside resistance training. They out-gained the placebo group on the bench press (+46.0 kg vs +26.4 kg) and leg extension, with greater arm and chest size and a bigger drop in body fat.⁶ A 2023 trial in trained men and women found improvements in strength and endurance in both sexes.⁷

Encouraging: but read it honestly. These are small studies, often in untrained beginners (who improve fast on almost anything), and several are linked to supplement manufacturers. The effect on muscle size specifically is inconclusive across the literature. This is a “might add a little” supplement for training, not a difference-maker on the order of, say, progressive overload and eating enough protein.

Evidence grade: early-to-moderate. Promising RCTs, but small, beginner-heavy, and some industry-funded, treat as a possible minor edge, not a driver.

The safety talk: the part that actually matters

This is where ashwagandha parts ways with the “totally benign” supplements, and where you earn a client’s trust by being the one who tells them.

Liver injury is real, if rare. A 2023 case series from India documented liver injury from single-ingredient ashwagandha products, usually as cholestatic hepatitis. Most cases were prolonged but resolved. Three patients who already had chronic liver disease presented with acute-on-chronic liver failure, and all three died.⁹ Similar cases have been reported from the US, Iceland and Japan.^13, 14 A 2026 critical review catalogues gastrointestinal, immune, liver and endocrine adverse effects, particularly with prolonged or excessive use.¹⁰ Published cases are few compared with how widely it is used, but no study has measured the true rate, and long-term safety has not been established. That is why this isn’t a “take it forever” default.

Pregnancy and trying to conceive: a clear no. The WHO and regulators have raised concerns, and a 2025 safety review lists pregnant women as a high-risk group.^11, 12 A separate 2025 systematic review found the evidence of harm to a developing baby inconclusive, and questioned how well-sourced the old reports of traditional abortifacient use are.¹¹ Inconclusive is not the same as safe, so the honest coaching answer is simply: not during pregnancy or while trying to conceive.

Thyroid and medications: screen first. It can nudge thyroid hormones (a modest T4 rise in the meta-analysis⁸), and a 2025 safety review specifically flags people with thyroid disorders, or with liver or kidney problems, as higher-risk.¹² A 2026 review also links it to rare thyrotoxicosis and warns about interactions with prescribed drugs, so anyone on thyroid or other prescription medication should check with their doctor first.¹⁰

Evidence grade: the risk is real but low-frequency. The right coaching posture isn’t fear, it’s screening. Not pregnant, no liver or thyroid condition, cleared by their doctor if on prescription medication, using a single-ingredient standardised extract, and for a set trial period (most studies ran about 8 weeks) rather than indefinitely, because long-term safety hasn’t been studied.^4, 10

The two myths that trip clients up

“It’s basically a natural testosterone booster”

Oversold. The 23-trial meta-analysis found testosterone rose by about 57 ng/dL in men, a modest bump, and showed no significant change in women.⁸ That’s a nudge, not a cycle. If a male client feels better on it, the likelier route is better sleep and lower stress, not a hormonal transformation. Frame it that way and you’ll never oversell it.

“It’s natural, so it’s safe to take every day forever”

This is the dangerous one, and you now have the receipts to counter it. Natural compounds still get metabolised by the liver, and ashwagandha has documented liver-injury reports to prove the point.^9, 10 “Natural” describes where a molecule comes from, not whether it’s safe at any dose for any person indefinitely. Use it for a set period, screen for it, and treat it with the same respect you’d give anything pharmacologically active.

What’s about to be proven (the part nobody else shows you)

Here’s the live edge of the field. Right now the registry lists 16 ashwagandha trials recruiting or about to start,¹⁵ and the pattern tells you where this is heading: straight at your female clients’ questions.

The cluster to watch is women’s health. There’s a three-arm randomised trial testing a proprietary ashwagandha extract for menopausal hot flashes, another on female stress and biology, and a combination study pairing it with shatavari for menopausal symptoms. Menopause and perimenopause are exactly the moments when stress, sleep and mood converge, and where your female clients are actively hunting for options. Nobody can claim ashwagandha is proven for menopause yet; the trials reading out over the next year will tell us. But you want to be the coach who knew the question was coming.

The other live thread is recovery: trials are now pairing ashwagandha with whey protein in physically active men and women, and testing it on strength and perceived recovery in athletes. We’ll update this piece as those read out, that’s the point of an evidence page that’s alive instead of frozen.

Your script for Monday

When the next client asks, here’s the whole thing in plain language:

“Ashwagandha’s best evidence is for stress, anxiety and sleep: that’s where you’re most likely to actually feel it, usually after about eight weeks at 300 to 600 milligrams a day of a standardised extract. The muscle and testosterone claims are real but small and oversold, so don’t buy it for that. And here’s the part most people skip: it’s not risk-free just because it’s natural. There are real, if rare, liver-injury cases, so use it for a set trial period, not forever. If you’re pregnant or trying to conceive, have a thyroid or liver condition, or take prescription medication, don’t start it without talking to your doctor. Otherwise, if stress and sleep are your issue, it’s a reasonable thing to trial.”

That’s it. No hype, no fear, no “natural so it’s fine.” Just the evidence, including the safety part, translated into something a human can act on. Which is the entire job.

Sqwod reads the research so your clients don’t have to. This is coaching information, not medical advice; anything involving a medical condition, pregnancy, medication, or a possible reaction belongs with a qualified professional. Spotted something that needs sharpening? That’s how an evidence page stays honest: tell us and we’ll correct it in public.